न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

viatris limited - amisulpride 400mg;   - film coated tablet - 400 mg - active: amisulpride 400mg   excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry white y-1-7000 sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

viatris limited - amisulpride 100mg;   - tablet - 100 mg - active: amisulpride 100mg   excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

viatris limited - amisulpride 200mg;   - tablet - 200 mg - active: amisulpride 200mg   excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

viatris limited - amisulpride 50mg - tablet - 50 mg - active: amisulpride 50mg excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - dolutegravir sodium 52.6mg equivalent to dolutegravir 50 mg;  ;  ;   - film coated tablet - 50 mg - active: dolutegravir sodium 52.6mg equivalent to dolutegravir 50 mg       excipient: mannitol microcrystalline cellulose opadry yellow 85f92461 povidone sodium starch glycolate sodium stearyl fumarate - tivicay is indicated for the treatment of human immunodeficiency virus (hiv) infection in combination with other antiretroviral agents in adults and children over 12 years of age and weighing 40 kg or more.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - idelalisib 100mg;   - film coated tablet - 100 mg - active: idelalisib 100mg   excipient: croscarmellose sodium hyprolose opadry orange 85f130017; formulation provided magnesium stearate microcrystalline cellulose sodium starch glycolate - zydelig is indicated in combination with rituximab for the treatment of patients with chronic lymphocytic leukaemia (cll)/small lymphocytic leukaemia (sll), including patients with 17p deletion or tp53 mutation, upon relapse after at least one prior therapy in patients for whom chemo-immunotherapy is not considered suitable. zydelig is not recommended for first-line treatment of cll/sll.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

wockhardt limited - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide 25 mg - zonisamide capsule is an antiseizure drug chemically classified as a sulfonamide and unrelated to other antiseizure agents. the active ingredient is zonisamide, 1,2-benzisoxazole-3-methanesulfonamide. the empirical formula is c8 h8 n2 o3 s with a molecular weight of 212.23. zonisamide is a white powder, pka = 10.2, and is moderately soluble in water (0.80 mg/ml) and 0.1 n hcl (0.50 mg/ml). the chemical structure is: zonisamide capsules are supplied for oral administration as capsules containing 25 mg, 50 mg and 100 mg zonisamide. each capsule contains the labeled amount of zonisamide plus the following inactive ingredients: microcrystalline cellulose, sodium lauryl sulfate, hydrogenated vegetable oil, colloidal silicon dioxide, sodium starch glycolate, talc, gelatin, titanium dioxide. for 100 mg d&c red # 28, d&c yellow # 10, and fd&c # yellow 6 and for 50 mg contains fd&c red # 40, fd&c yellow # 5, and fd&c blue # 1.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

stat rx usa llc - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide 25 mg - zonisamide capsule is an antiseizure drug chemically classified as a sulfonamide and unrelated to other antiseizure agents. the active ingredient is zonisamide, 1,2-benzisoxazole-3-methanesulfonamide. the empirical formula is c8 h8 n2 o3 s with a molecular weight of 212.23. zonisamide is a white powder, pka = 10.2, and is moderately soluble in water (0.80 mg/ml) and 0.1 n hcl (0.50 mg/ml). the chemical structure is: zonisamide capsules are supplied for oral administration as capsules containing 25 mg, 50 mg and 100 mg zonisamide. each capsule contains the labeled amount of zonisamide plus the following inactive ingredients: microcrystalline cellulose, sodium lauryl sulfate, hydrogenated vegetable oil, colloidal silicon dioxide, sodium starch glycolate, talc, gelatin, titanium dioxide. for 100 mg d&c red # 28, d&c yellow # 10, and fd&c # yellow 6 and for 50 mg contains fd&c red # 40, fd&c yellow # 5, and fd&c blue # 1.

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - acetazolamide - oral tablet - 250mg

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - tolterodine tartrate - oral tablet - 2mg